VR-guided slow breathing with mystical visuals for stress relief
Official title: Assessing the Acute Effects of Virtual Reality Interventions on Stress: A Four-Arm RCT
Run by University of Basel · NCT07191288 · Data updated 2026-11-12
This trial tests whether combining slow-paced breathing with immersive 'mystical' virtual reality reduces stress in healthy German-speaking adults aged 18-35 with elevated perceived stress.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 35 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | University of Basel Academic / other |
| Locations | 1 site (Basel, Canton of Basel-City) |
| Status | Recruiting |
| Started | March 5, 2026 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | November 3, 2026 |
| Trial ID | NCT07191288 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are healthy, German-speaking adults aged 18-35 with elevated perceived stress (PSQ-30 > 60) and no current psychiatric diagnoses or chronic medication use.
✕Probably not a fit
People with current psychiatric conditions, high depressive symptoms or suicidal ideation, uncorrected visual impairment, chronic medication use (except contraceptives), non-German speakers, or those outside the 18-35 age range are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized, four-arm trial comparing an immersive VR slow-breathing intervention with mystical elements, a VR mystical-only condition, a non-VR computer-guided slow-breathing condition, and a VR control. Participants are healthy, German-speaking adults aged 18-35 with elevated perceived stress (PSQ-30 > 60) who are randomized to a single acute session and monitored for subjective and physiological stress markers. Outcomes include self-reported stress measures and physiological indicators such as heart rate and heart rate variability collected before, during, and after the interventions. Key exclusions include current psychiatric diagnoses, high depressive symptoms (PHQ-9 >= 10 or suicidal ideation), chronic medication use, and uncorrected visual impairment.
Why it matters
Potential benefit: If successful, the intervention could offer a fast, non-drug, scalable way to reduce acute stress using VR-guided breathing.
How similar studies have gone: Previous research shows slow-paced breathing and biofeedback can reduce stress and VR relaxation protocols have shown promise, but combining breathing with mystical-type immersive VR elements is a relatively new approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * \> 60 points on the PSQ-30 out of a maximum 120-point scale in the screening * Healthy * Aged between 18-35 * Fluent in German Exclusion Criteria: * A current diagnosis of psychiatric disorders (self-reported) * Chronic medication use (except oral contraceptives) * Parallel participation in another medical or psychological study * Suicidal tendencies (PHQ-9 item 9 \> 0)3 * PHQ-9 score ≥ 10 * A visual impairment not corrected by glasses or contact lenses
Where it's running
-
University of Basel, Division of Cognitive Neuroscience
Basel, Canton of Basel-City, Switzerland Recruiting
Study contacts
- Study coordinator: Fabian Mueller, Msc
- Email: fabi.mueller@unibas.ch
- Phone: +41612070272
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Color of the defect and enamel breakdown in MIH-affected first molars
This study tests whether the color of the enamel defect in kids with MIH can predict enamel breakdown in their first permanent molars.
-
Colour and sensitivity in first permanent molars with MIH
This study tests whether the colour of enamel defects in first permanent molars with MIH correlates with hypersensitivity in affected children.
-
Comparing biomarkers in regular cannabis users and non-users to find signs of recent inhalation
We will test whether specific blood or other biological markers can indicate how recently regular cannabis smokers last inhaled by comparing them with non-users.
-
Animal-assisted occupational therapy to boost brain signal complexity in minimally conscious adults
We will try animal-assisted occupational therapy to see if it increases brain signal complexity in adults who are in a minimally conscious state.
-
Fampridine for working memory in mild to moderate depression
This trial will test whether taking fampridine improves working memory in adults with mild to moderate depression.
-
Exercise program for children born prematurely to improve heart health and cognitive function
This study is testing whether a fun exercise program can help improve heart health and thinking skills in children aged 6 to 12 who were born prematurely.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.